Xeris Pharmaceuticals secures $85 mln debt facility

Xeris Pharmaceuticals, a specialty pharmaceutical company, has secured a $85 million debt facility from Oxford Finance LLC and Silicon Valley Bank. The debt facility will be used by Xeris to provide "greater financial flexibility and additional access to capital."

North AmericaUSCreditBriefs